Covishield's human trial continues in Pune hospital, the dose will be given to 6 people

New Delhi: Oxford University and AstraZeneca Company are engaged in preparations for making a Coronavirus vaccine in association with the Serum Institute of India. This vaccine will be launched under the name Covishield (AZD1222). A second phase trial of the vaccine is starting in Pune today. 6 people will be given this dose at 1 pm today at Bharti Vidyapeeth Medical College and Hospital. If the results are positive then 300 to 350 people will be given this vaccine.

Om Birla reminds Rules and Regulations to chairpersons of Parliamentary Committee

While giving the information, Dr. Sanjay Lalwani, Medical Director, Medical College and Hospital, Pune-based Bharti Vidyapeeth, said that we have selected 6 people for the trial. The screening process for these people ended. RT-PCR and antibody tests have been performed. The Serum Institute of India has tied up with the British-Swedish pharmaceutical firm AstraZeneca to produce 1 billion doses of the Corona vaccine in the country.

Ashok Gehlot government trapped in legal odds

According to the report published in the medical journal The Lancet, this vaccine is completely safe and effective. After this information, Oxford's vaccine has come forward in the list of front runner vaccines. Oxford University has also stated that applying this vaccine named AZD1222 has yielded a positive immune response.

Family going from Dumka to Devghar became victims of the accident while traveling

- Sponsored Advert -

Most Popular

- Sponsored Advert -